These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3749402)

  • 61. Clinical and magnetic resonance imaging correlates of hypothalamic-pituitary-adrenal axis function in depression and Alzheimer's disease.
    O'Brien JT; Ames D; Schweitzer I; Colman P; Desmond P; Tress B
    Br J Psychiatry; 1996 Jun; 168(6):679-87. PubMed ID: 8773809
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Plasma corticosterone and cortisol following dexamethasone in psychiatric patients.
    Arana GW; Wilens TE; Baldessarini RJ
    Psychoneuroendocrinology; 1985; 10(1):49-60. PubMed ID: 4001277
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression.
    Holsboer F; von Bardeleben U; Wiedemann K; Müller OA; Stalla GK
    Biol Psychiatry; 1987 Feb; 22(2):228-34. PubMed ID: 3028512
    [No Abstract]   [Full Text] [Related]  

  • 64. Plasma endogenous opioids and dexamethasone suppression test in depression.
    Kärkkäinen J; Laatikainen T; Naukkarinen H; Salminen K; Spoov J; Stenman UH; Rimon R
    Psychiatry Res; 1987 Jun; 21(2):151-9. PubMed ID: 2956623
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression.
    Roy A; Pickar D; De Jong J; Karoum F; Linnoila M
    Arch Gen Psychiatry; 1988 Sep; 45(9):849-57. PubMed ID: 3415426
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparative dexamethasone suppression test measurements in bulimia, depression and normal controls.
    Musisi S; Garfinkel P
    Can J Psychiatry; 1985 Apr; 30(3):190-4. PubMed ID: 3857956
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus.
    Cameron OG; Kronfol Z; Greden JF; Carroll BJ
    Arch Gen Psychiatry; 1984 Nov; 41(11):1090-5. PubMed ID: 6497572
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The influence of weight loss on the dexamethasone suppression test.
    Yerevanian BI; Baciewicz GJ; Iker HP; Privitera MR
    Psychiatry Res; 1984 Jun; 12(2):155-60. PubMed ID: 6591220
    [TBL] [Abstract][Full Text] [Related]  

  • 70. DST in bulimia without endogenous depression.
    Levy AB; Dixon KN
    Biol Psychiatry; 1987 Jun; 22(6):783-6. PubMed ID: 3593818
    [No Abstract]   [Full Text] [Related]  

  • 71. The metyrapone test in depressed males.
    Morphy MA; Fava GA; Perini GI; Molnar G
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(2):187-91. PubMed ID: 4001433
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels.
    Holsboer-Trachsler E; Buol C; Wiedemann K; Holsboer F
    Acta Psychiatr Scand; 1987 Jun; 75(6):608-13. PubMed ID: 3618283
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dexamethasone suppression test identifies a subset of elderly depressed patients with reduced platelet serotonin transport and resistance to imipramine inhibition of transport.
    Slotkin TA; Hays JC; Nemeroff CB; Carroll BJ
    Depress Anxiety; 1997; 6(1):19-25. PubMed ID: 9394871
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cortisol levels in plasma after dexamethasone administration and the nosology of depression.
    Sanchez Blanque A; Fernandez Canti G; Gimenez Morales JC; Juste Rullo G
    Acta Psychiatr Belg; 1985; 85(3):406-15. PubMed ID: 4050499
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia.
    Jakovljević M; Mück-Seler D; Pivac N; Crncević Z
    Neuropsychobiology; 1998; 37(3):142-5. PubMed ID: 9597670
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The relationship of dexamethasone suppression to psychological test variables.
    Danahy SA; Schwartz BD; Willard SG; Winstead DK
    J La State Med Soc; 1986 Jan; 138(1):38-43. PubMed ID: 3950587
    [No Abstract]   [Full Text] [Related]  

  • 77. Plasma postdexamethasone cortisol levels in schizoaffective disorder.
    Meador-Woodruff JH; Greden JF; Grunhaus L; Haskett RF
    Psychiatry Res; 1988 Oct; 26(1):35-42. PubMed ID: 3237905
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder.
    Yehuda R; Southwick SM; Krystal JH; Bremner D; Charney DS; Mason JW
    Am J Psychiatry; 1993 Jan; 150(1):83-6. PubMed ID: 8417586
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The dexamethasone suppression test and pituitary-adrenocortical function.
    Brown WA; Keitner G; Qualls CB; Haier R
    Arch Gen Psychiatry; 1985 Feb; 42(2):121-3. PubMed ID: 3977539
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The limbic-hypothalamic-pituitary-adrenal axis in Huntington's disease.
    Heuser IJ; Chase TN; Mouradian MM
    Biol Psychiatry; 1991 Nov; 30(9):943-52. PubMed ID: 1660734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.